CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study This study includes the PanCareSurFup and ProCardio cohort of ≥ 5 ...
People with heart failure may live for many years and should continue to get regular cancer screenings, experts say. By Nicholas Bakalar People with heart failure may be at increased risk for cancer.
A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain people ...
Cell therapy, involving adult stem cells from bone marrow, has been shown to reduce the risk of heart attack and stroke in severe heart failure patients, according to a new study. A single ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results